Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South is a research paper published in Open Forum Infectious Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 65 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Center for AIDS Research, Emory University
Grant: P30-AI-050409
Georgia CTSA
Grant: UL1TR002378
Georgia CTSA
Grant: KL2-TL1TR002381
NIH
Grant: R01MH123396
NCATS NIH HHS
Grant: KL2 TR002381
NIA NIH HHS
Grant: U54 AG062334
National Institutes of Health
Grant: 5UL1TR002378-09
Georgia Clinical & Translational Science Alliance (Georgia CTSA)
National Institutes of Health
Grant: 5R01MH123396-03
Understanding Patient, Provider, and Systems Stakeholder Attitudes and Preferences to Optimize Implementation of Long-Acting Injectable Antiretrovirals and Maximize Clinical and Public Health Impact
National Institutes of Health
Grant: 1KL2TR002381-01
Institutional Career Development
National Institutes of Health
Grant: 5P30AI050409-20
Center for AIDS Research at Emory University
Doris Duke Charitable Foundation
National Institute of Mental Health
Emory School of Medicine
National Institutes of Health
National Center for Advancing Translational Sciences
Program for Retaining, Supporting, and EleVating Early-career Researchers at Emory
FWCI
5.68
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals